UCTV Seminars

description:

Project Accept is part of the HIV Prevention Trials Network (HPTN), "a worldwide collaborative clinical trials network that develops and tests the safety and efficacy of interventions designed to prevent the acquisition and transmission of HIV. The HPTN research agenda is focused primarily on reduction of HIV transmission and acquisition through the use of ART for HIV-infected persons and ARVs as pre-exposure prophylaxis (PrEP) for HIV-negative persons for HIV prevention, reducing the impact of behavioral and biologic cofactors that increase risk of infection, treatment of substance use (particularly injection drug use), behavioral risk reduction interventions, and structural interventions. The highest priority of the HPTN is to develop and implement combination prevention strategies that demonstrate a significant and measurable reduction in HIV incidence in a variety of populations and epidemic settings."

more on this subject:

The MET Receptor Tyrosine Kinase and Autism Risk

Bill and Melinda Gates Foundation's Grand Challenges Explorations Grant Program

Fragrance Chemicals: What's the Stink?

see all from Public Health >

host links:

GHREAT Website
GHREAT Works Series on UCTV